Trade Amgen ^AMGN

Amgen Inc. $AMGN Shares Bought by German American Bancorp Inc. - Zolmax

Modera Wealth Management LLC Sells 4,769 Shares of Amgen Inc. $AMGN

California Public Employees Retirement System Has $693.38 Million Stock Holdings in Amgen Inc. $AMGN - Markets Daily

Amgen Inc. $AMGN Stock Position Lowered by California Public Employees Retirement System

Amgen Inc. $AMGN Holdings Decreased by Bartlett & CO. Wealth Management LLC

John G Ullman & Associates Inc. Sells 6,675 Shares of Amgen Inc. $AMGN - Stock Observer

Atlas Wealth LLC Has $25.50 Million Position in Amgen Inc. $AMGN

Amgen (AMGN) Earnings Buzz Builds, Is The Stock Already Overvalued?

Atlas Wealth LLC Increases Stake in Amgen Inc. $AMGN - Stock Observer

The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?

SteelPeak Wealth LLC Acquires 20,118 Shares of Amgen Inc. $AMGN

Assetmark Inc. Purchases 15,719 Shares of Amgen Inc. $AMGN

Assetmark Inc. Boosts Stake in Amgen Inc. $AMGN - Stock Observer

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

Wealthfront Advisers LLC Boosts Position in Amgen Inc. $AMGN

D.A. Davidson & CO. Trims Stake in Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Sold by Bank of New York Mellon Corp

Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results

Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage

Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models

Research Analysts' Weekly Ratings Changes for Amgen (AMGN) - Stock Observer

New machine learning model improves cholesterol calculation accessibility

Amgen's Tablet Recalls Test Its Quality Controls and Manufacturing Ambitions (AMGN)

Livforsakringsbolaget Skandia Omsesidigt Increases Stake in Amgen Inc. $AMGN - Stock Observer

AMG National Trust Bank Acquires 3,523 Shares of Amgen Inc. $AMGN - Stock Observer

Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen

Bleakley Financial Group LLC Purchases 3,526 Shares of Amgen Inc. $AMGN - Markets Daily

Calamos Advisors LLC Buys 3,648 Shares of Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Sold by Mattern Capital Management LLC - Daily Political

Amgen (AMGN) Recalls Corlanor And Sensipar Nationwide Over Quality Control Issues

2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down

Cue Biopharma Appoints Dominic Borie As CMO

Guggenheim Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price

Amgen (NASDAQ:AMGN) Price Target Raised to $343.00 - Zolmax

An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial

Amgen Inc. $AMGN Shares Acquired by Ferguson Wellman Capital Management Inc.

Fifth Third Bancorp Boosts Stock Position in Amgen Inc. $AMGN - Markets Daily

Fifth Third Bancorp Acquires 167,835 Shares of Amgen Inc. $AMGN

Castleview Partners LLC Has $2.77 Million Holdings in Amgen Inc. $AMGN - Daily Political

Candriam S.C.A. Raises Holdings in Amgen Inc. $AMGN

Conning Inc. Has $33.85 Million Position in Amgen Inc. $AMGN

Candriam S.C.A. Buys 3,616 Shares of Amgen Inc. $AMGN - Daily Political

First Horizon Corp Boosts Holdings in Amgen Inc. $AMGN

Ibex Wealth Advisors Increases Stake in Amgen Inc. $AMGN

Explaining genetically engineered rodents to a jury-and ultimately beating Amgen

Amgen Inc. (NASDAQ:AMGN) Receives Average Recommendation of "Hold" from Analysts

AMGN: IRS Dispute And Regulatory Setbacks Will Pressure Future Returns

Truist Raises its Price Target on Amgen (AMGN)

Jim Cramer Says Biotech is The Hottest Group in The Market Right Now

RBC Capital Reaffirms Their Buy Rating on BridgeBio Pharma (BBIO)

Regeneron Narrows Amgen Challenges in Case Over Eylea Biosimilar

Amgen Inc. $AMGN Holdings Cut by Swedbank AB

Unrivaled 2026: Jonathan Polkes of White & Case

How Safe Is Amgen's Dividend? - AOL

Jim Cramer Calls Biotech "The Hottest Group in the Market" as He Predicts "Deals Are Going to Be Flooding the Market" - 24/7 Wall St.

Kiley Juergens Wealth Management LLC Makes New $1.25 Million Investment in Amgen Inc. $AMGN - Stock Observer

Amgen Inc. $AMGN Shares Sold by Burney Co.

Going beyond cycling versus swapping for treatment sequencing in psoriatic arthritis

Opinion: San Diego helped invent biotech and must now fight to keep it

Whittier Trust Co. of Nevada Inc. Grows Stock Holdings in Amgen Inc. $AMGN - Markets Daily

Amgen Inc. $AMGN Shares Bought by Stephens Inc. AR

Whittier Trust Co. of Nevada Inc. Has $7.86 Million Stake in Amgen Inc. $AMGN - Stock Observer

Amgen (AMGN) Could Be 45% Below Fair Value As Court Blocks Enbrel Price Cap

Amgen Inc. $AMGN Shares Sold by Raleigh Capital Management Inc. - Daily Political

Amgen Inc. $AMGN Shares Purchased by QRG Capital Management Inc.

Boston Trust Walden Corp Increases Holdings in Amgen Inc. $AMGN - Markets Daily

Strs Ohio Lowers Position in Amgen Inc. $AMGN

Strs Ohio Cuts Stake in Amgen Inc. $AMGN

Global Cervical Cancer Treatment Market to Reach USD 14.43 Billion by 2034, Growing at a CAGR of 5.48%

Amgen Inc. $AMGN Shares Sold by Fideuram Intesa Sanpaolo Private Banking S.P.A.

Amgen Inc. $AMGN Holdings Raised by Elevation Point Wealth Partners LLC - Stock Observer

Trump 'thinks' he'll visit Doonbeg in September, praises 'fighting Irish' in special message

Does Tavneos Retraction And Possible Withdrawal Reshape The Bull Case For Amgen (AMGN)?

Amgen Inc. $AMGN Stake Lessened by Fulton Bank N.A.

Fulton Bank N.A. Has $5.12 Million Holdings in Amgen Inc. $AMGN - Stock Observer

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years

Casdatifan 在肾癌中表现出与 HIF-2α 生物学相关的持久疗效

Mizuho Highlights Amgen (AMGN) Pipeline Potential With MariTide and Olpasiran

IFM Investors Pty Ltd Increases Holdings in Amgen Inc. $AMGN

Eagle Wealth Advisors LLC Acquires New Shares in Amgen Inc. $AMGN

USS Investment Management Ltd Raises Holdings in Amgen Inc. $AMGN - Stock Observer

Feasibility and safety of rapid glofitamab ramp-up

Amgen Faces Fresh Pressure After NEJM Retracts Trial Behind $459 Million Drug

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

Lansforsakringar Fondforvaltning AB publ Sells 24,304 Shares of Amgen Inc. $AMGN - Zolmax

Amgen Inc. $AMGN Stock Position Lowered by Lansforsakringar Fondforvaltning AB publ

FDA Investigation Leads to Retraction of Amgen's Tavneos Drug Trial Study, ETPharma

Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer

Amgen Inc. $AMGN Shares Acquired by Patriot Financial Group Insurance Agency LLC - Markets Daily

Amgen Inc. $AMGN Holdings Lifted by Fort Washington Investment Advisors Inc. OH

Weekly Investment Analysts' Ratings Updates for Amgen (AMGN) - Daily Political

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis